Rafarma Pharmaceuticals, Inc. (RAFA)

Rafarma Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Assets

Fiscal Year	FY 2012	FY 2011
Period Ending	Mar 31, 2012	Mar 31, 2011
Cash & Equivalents	0.12	0.09
Cash & Short-Term Investments	0.12	0.09
Cash Growth	27.22%	-
Inventory	0.14	0.27
Total Current Assets	0.26	0.37
Long-Term Investments	327.73	-
Other Intangible Assets	2	2
Total Assets	329.99	2.37

Liabilities

Fiscal Year	FY 2012	FY 2011
Period Ending	Mar 31, 2012	Mar 31, 2011
Long-Term Debt	0.24	0.23
Total Liabilities	0.24	0.23

Shareholders' Equity

Fiscal Year	FY 2012	FY 2011
Period Ending	Mar 31, 2012	Mar 31, 2011
Common Stock	0.08	0.08
Additional Paid-In Capital	329.43	2
Retained Earnings	-0.06	0.05
Total Common Equity	329.45	2.13
Shareholders' Equity	329.75	2.13
Total Liabilities & Equity	329.99	2.37

Additional Metrics

Fiscal Year	FY 2012	FY 2011
Period Ending	Mar 31, 2012	Mar 31, 2011
Total Debt	0.24	0.23
Net Cash (Debt)	-0.12	-0.14
Net Cash Growth	-	-
Net Cash Per Share	-0.02	-0.02
Filing Date Shares Outstanding	8.14	8.14
Total Common Shares Outstanding	8.14	8.14
Working Capital	0.26	0.37
Book Value Per Share	40.49	0.26
Tangible Book Value	327.45	0.13
Tangible Book Value Per Share	40.24	0.02

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2012

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every year for this company.

Update frequency:

Yearly

Last checked:

Jul 24, 2026

Data Sources Report a data error